T Man Pharmaceutical PCL
SET:TMAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
TH |
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
KR |
|
C
|
CI Group PCL
SET:CIG
|
TH |
|
T
|
Toosla SA
PAR:ALTOO
|
FR |
|
U-Next Holdings Co Ltd
OTC:USNNF
|
JP |
|
B
|
BBI Buergerliches Brauhaus Immobilien AG
XMUN:BBI
|
DE |
Wall Street
Price Targets
TMAN Price Targets Summary
T Man Pharmaceutical PCL
According to Wall Street analysts, the average 1-year price target for TMAN is 18.16 THB with a low forecast of 17.98 THB and a high forecast of 18.69 THB.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TMAN's stock price target?
Price Target
18.16
THB
According to Wall Street analysts, the average 1-year price target for TMAN is 18.16 THB with a low forecast of 17.98 THB and a high forecast of 18.69 THB.
What is T Man Pharmaceutical PCL's Revenue forecast?
Projected CAGR
12%
For the last 2 years the compound annual growth rate for T Man Pharmaceutical PCL's revenue is 13%. The projected CAGR for the next 2 years is 12%.
What is T Man Pharmaceutical PCL's Operating Income forecast?
Projected CAGR
8%
For the last 2 years the compound annual growth rate for T Man Pharmaceutical PCL's operating income is 11%. The projected CAGR for the next 2 years is 8%.
What is T Man Pharmaceutical PCL's Net Income forecast?
Projected CAGR
2%
For the last 2 years the compound annual growth rate for T Man Pharmaceutical PCL's net income is 10%. The projected CAGR for the next 2 years is 2%.
